Cancer without recurrence for 5 years is considered to be clinically cured, and the clinical cure rate of vaginal cancer is related to the stage and tumor pathology type.
Vaginal cancer is divided into four stages according to the degree of tumor progression. Stage I vaginal cancer is confined to the vaginal wall, at this time, the clinical cure rate is about 73%; Stage II tumor infiltrates the paravaginal tissues but does not reach the pelvic wall, the clinical cure rate is about 48%.
Stage III tumor extends to the pelvic wall, stage IV exceeds the true pelvis spreading to the bladder, rectal mucosa, or distant metastasis, at this time the clinical cure rate is lower, 28% and 11% respectively.
The most common pathologic type of vaginal cancer is squamous carcinoma, and less common are adenocarcinoma and vaginal melanoma. Generally speaking, after standardized treatment, vaginal squamous carcinoma has the highest clinical cure rate, with a 5-year overall survival rate of 35% to 78%, followed by adenocarcinoma, and melanoma has the worst prognosis. The cure rate is also affected by the treatment program, patient’s age, physical fitness and so on.
If patients suspect or diagnose vaginal cancer, they should seek medical treatment as early as possible and actively carry out treatment under the guidance of professional doctors to avoid delaying the condition. Consultation with professional doctors is recommended for specific cases.